These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6416540)

  • 1. Reversal of insulin resistance in type I diabetes after treatment with continuous subcutaneous insulin infusion.
    Lager I; Lönnroth P; von Schenck H; Smith U
    Br Med J (Clin Res Ed); 1983 Dec; 287(6406):1661-4. PubMed ID: 6416540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-mediated glucose disposal in type 1 (insulin-dependent) diabetic subjects treated by continuous subcutaneous or intraperitoneal insulin fusion.
    Beylot M; Khalfallah Y; Laville M; Sautot G; Dechaud H; Serusclat P; Berthezene F; Riou JP; Mornex R
    Diabete Metab; 1987; 13(4):450-6. PubMed ID: 3315766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance in multiple tissues in patients with type 1 diabetes mellitus on long-term continuous subcutaneous insulin infusion therapy.
    Donga E; van Dijk M; Hoogma RP; Corssmit EP; Romijn JA
    Diabetes Metab Res Rev; 2013 Jan; 29(1):33-8. PubMed ID: 22936679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-mediated glucose disposal in type I diabetes: evidence for insulin resistance.
    Del Prato S; Nosadini R; Tiengo A; Tessari P; Avogaro A; Trevisan R; Valerio A; Muggeo M; Cobelli C; Toffolo G
    J Clin Endocrinol Metab; 1983 Nov; 57(5):904-10. PubMed ID: 6352727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sensitivity to insulin in type I diabetes. Preliminary report].
    Pernet A; Kuntschen F; Trimble ER; Assal JP; Hahn C; Renold AE
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1917-9. PubMed ID: 6364337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous insulin substitution in insulin-dependent diabetes mellitus. Pharmacokinetic and pharmacodynamic studies.
    Olsson PO
    Acta Med Scand Suppl; 1987; 718():1-78. PubMed ID: 3321929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L; Sherwin R; Hendler R; Felig P
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of optimal glycaemic control with continuous subcutaneous insulin infusion on energy expenditure in type I diabetes mellitus.
    Leslie P; Jung RT; Isles TE; Baty J; Newton RW; Illingworth P
    Br Med J (Clin Res Ed); 1986 Nov; 293(6555):1121-6. PubMed ID: 3094802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous subcutaneous insulin infusion:good blood glucose control for up to 4 days.
    Pickup JC; Keen H; Parsons JA; Alberti KG
    Diabetologia; 1979 Jun; 16(6):385-9. PubMed ID: 467848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump.
    Tamborlane WV; Sherwin RS; Genel M; Felig P
    N Engl J Med; 1979 Mar; 300(11):573-8. PubMed ID: 763270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous intraperitoneal insulin infusion partly restores the glucagon response to hypoglycaemia in type 1 diabetic patients.
    Oskarsson PR; Lins PE; Backman L; Adamson UC
    Diabetes Metab; 2000 Apr; 26(2):118-24. PubMed ID: 10804326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calculating the insulin to carbohydrate ratio using the hyperinsulinaemic-euglycaemic clamp-a novel use for a proven technique.
    Bevier WC; Zisser H; Palerm CC; Finan DA; Seborg DE; Doyle FJ; Wollitzer AO; Jovanovic L
    Diabetes Metab Res Rev; 2007 Sep; 23(6):472-8. PubMed ID: 17315240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre- and postprandial hyperinsulinemia during insulin pump treatment; role of the subcutaneous bolus and basal infusion.
    Olsson PO; Jorfeldt L; Arnqvist H; Gerhardsson P
    Diabetes Res; 1991 Feb; 16(2):55-61. PubMed ID: 1817806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance in Type 1 (insulin-dependent) diabetes: dependence on plasma insulin concentration.
    Pernet A; Trimble ER; Kuntschen F; Damoiseaux P; Assal JP; Hahn C; Renold AE
    Diabetologia; 1984 Apr; 26(4):255-60. PubMed ID: 6376232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous subcutaneous insulin infusion: comparison of plasma insulin profiles after infusion or bolus injection of the mealtime dose.
    Home PD; Pickup JC; Keen H; Alberti KG; Parsons JA; Binder C
    Metabolism; 1981 May; 30(5):439-42. PubMed ID: 6112654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between multi-injection and continuous subcutaneous insulin therapy in insulin-dependent diabetic inpatients.
    Saibene V; Melandri M; Brembilla L; Spotti D; Pozza G
    Acta Diabetol Lat; 1981; 18(1):45-50. PubMed ID: 7010856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous subcutaneous insulin infusion therapy decreases insulin resistance in type 1 diabetes.
    Yki-Järvinen H; Koivisto VA
    J Clin Endocrinol Metab; 1984 Apr; 58(4):659-66. PubMed ID: 6365945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion.
    Liebl A; Hoogma R; Renard E; Geelhoed-Duijvestijn PH; Klein E; Diglas J; Kessler L; Melki V; Diem P; Brun JM; Schaepelynck-Bélicar P; Frei T;
    Diabetes Obes Metab; 2009 Nov; 11(11):1001-8. PubMed ID: 19740082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of insulin resistance in type I diabetes.
    Kerner W; Navascués I; von Schrenck T; Fussgänger R; Arias P; Pfeiffer EF
    Klin Wochenschr; 1985 Jun; 63(12):545-53. PubMed ID: 3897693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-dependent diabetic patients during surgery and labour. Use of continuous intravenous insulin-glucose-potassium infusions.
    Bowen DJ; Daykin AP; Nancekievill ML; Norman J
    Anaesthesia; 1984 May; 39(5):407-11. PubMed ID: 6375445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.